An Introspective on Immunotherapy

An Introspective on Immunotherapy

11 January 2015,   By ,   0 Comments

This Tuesday, the OncoSec team will play host to some of the most brilliant minds in immuno-oncology, with our highly anticipated symposium, “An Introspective on Immunotherapy: A Symposium on Intratumoral Therapy.” The event promises to be a notable high point during the week of J.P. Morgan’s annual healthcare conference, a week that has historically attracted the “who’s who” of the healthcare sector.

Speaker presentations will focus on the rationale and potential of intratumoral immunotherapy, with an emphasis on OncoSec’s role as a key leader in this field. The event’s agenda is as follows.

Presenters:

[one_fourth_first]

OncoSec_Headshot_Holbrook_Kohrt

Holbrook Kohrt, MD, PhD.

Stanford University

[/one_fourth_first]

OncoSec_Headshot_Robert_Andtbacka

Robert Andtbacka, MD

University of Utah

OncoSec_Headshot_Rob_Priece

Robert H. Pierce, MD

OncoSec Medical

OncoSec_Headshot_Mai_Le

Mai H. Le, MD

OncoSec Medical

 

AN INTROSPECTIVE ON IMMUNOTHERAPY
A SYMPOSIUM ON INTRATUMORAL THERAPY

Tuesday, January 13, 2015 | 5:00pm

The Palace Hotel
Twin Peaks South | Second Floor
2 New Montgomery Street
San Francisco | CA | 94105

Presentations and Panel Discussion (Q&A) | 5:00pm – 6:00pm

Cocktail Reception | 6:00pm – 7:00pm

After the symposium has concluded, a webcast will be made available via the following link: www.oncosec.com/jmp-immunotherapy-symposium-2015/

In Closing

We want to thank all attendees in advance for taking the time to learn more about the exciting field of intratumoral immunotherapy, and understand its place as a critical component of the emerging cancer treatment landscape. Immunotherapy is transforming oncology, and intratumoral approaches like OncoSec’s ImmunoPulse have the potential to fundamentally change how we treat cancer.

We are entering into a new era at OncoSec, as the world begins to recognize the true value of therapies that directly combat the immunosuppressive nature of cancers. During this pivotal time, we hope our symposium can inspire, inform, and leave attendees with a newfound understanding of both intratumoral immunotherapy and OncoSec’s role as a key leader in this space.

For more info or to RSVP: email jkopin@oncosec.com


Real Time Web Analytics